Health Care & Life Sciences » Pharmaceuticals | Tianda Pharmaceuticals Ltd.

Tianda Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values HKD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
247,173.10
139,366.80
192,784.80
195,539.00
361,554.60
527,002.80
Cost of Goods Sold (COGS) incl. D&A
88,692.50
69,596.40
82,055.60
75,523.90
91,195.10
102,923.10
Gross Income
158,480.60
69,770.40
110,729.10
120,015.10
270,359.50
424,079.70
SG&A Expense
100,732.90
104,813.10
102,402.10
102,560.90
255,386.20
414,847.30
EBIT
57,747.70
35,042.70
8,327.10
-
14,973.40
9,232.40
Unusual Expense
12.80
-
17.30
4,402.60
3,648.10
-
Non Operating Income/Expense
797.30
1,111.90
3,873.30
5,519.90
7,177.20
3,934.70
Interest Expense
-
32.60
-
-
-
-
Pretax Income
64,426.60
24,261.70
18,424.90
32,749.70
29,942.00
26,167.10
Income Tax
15,477.30
1,245.40
5,057.60
7,997.10
7,780.00
10,184.20
Consolidated Net Income
48,949.30
23,016.30
13,367.20
24,752.60
22,162.00
15,982.90
Net Income
22,049.60
17,942.00
6,568.60
12,442.30
10,007.80
2,657.20
Net Income After Extraordinaries
22,049.60
17,942.00
6,568.60
12,442.30
10,007.80
2,657.20
Net Income Available to Common
22,049.60
17,942.00
6,568.60
12,442.30
10,007.80
2,657.20
EPS (Basic)
0.01
0.01
0.00
0.01
0.00
-
Basic Shares Outstanding
1,870,118.20
1,870,118.20
2,050,232.00
2,150,635.90
2,150,620.30
2,150,191.90
EPS (Diluted)
0.01
0.01
0.00
0.01
0.00
-
Diluted Shares Outstanding
1,870,118.20
1,870,118.20
2,050,232.00
2,150,635.90
2,150,620.30
2,150,191.90
EBITDA
75,675.40
16,099.40
29,416.60
38,845.30
37,015.30
-
Non-Operating Interest Income
5,894.50
9,701.70
6,241.80
5,373.10
4,143.30
13,000
Minority Interest Expense
26,899.80
5,074.30
6,798.70
12,310.30
12,154.30
13,325.80

About Tianda Pharmaceuticals

View Profile
Address
Suites 2405-2410
Hong Kong
Hong Kong
Employees -
Website http://www.tiandapharma.com
Updated 07/08/2019
Tianda Pharmaceuticals Ltd. operates as an investment holding company, which engages in the research and development, manufacture and sale of pharmaceutical, biotechnology and healthcare products. It offers cardio-cerebrovascular, pediatric, cold and respiratory system, anti-infective, detoxification drugs and complementary Healthcare Products. The company is headquartered in Hong Kong.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.